In a summary of collected data from Intermountain Healthcare, Centura Health, and Virginia Mason Medical Center, you'll learn how PIVO is impacting each hospital system—from Intermountain's goal of becoming the nation's first "one-stick" hospitalization to Centura transforming their standard of care to Virginia Mason's drive to reduce CLABSI rates.
Billions of times a year in hospitals around the world, hospitals puncture patients with a sharp needle to draw blood. By challenging the status quo on common procedures previously thought immune to innovation, health systems can reimagine the patient experience and provide a better-coordinated standard of care.
Data validates the impact PIVO™ adoption has on delivering high quality care. In evaluating 210,310 patient visits over a two-year period, data supports improved IV replacement rates and higher clinical quality. Research supports a numerically lower IV replacement rate and a substantial reduction in lab error collection rates.
Virginia Mason Medical Center recognized a need to limit the risk of central line bloodstream infections (CLABSIs) by reducing CVC utilization for blood draws. The PIVO™ needle-free blood draw system was used to move blood draws to the periphery. Through a systematic approach in adopting four clinical practice changes, this quality improvement initiative sets a new standard for CVC utilization.
In this collection of clinical research studies, you'll learn how PIVO™ analyte results are equivalent to venipuncture, daily use of PIVO does not affect peripheral IV dwell time, and lower hemolysis rates can be achieved with PIVO when compared to current blood draw methods. There is also support that therapeutic drug monitoring can be successfully performed using PIVO, and there is no dilution after pre-flush when a blood sample is drawn using PIVO.